Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label multicenter phase 2 study of Allocetra-OTS in hospitalized adults with severe or critical COVID-19 and respiratory impairment
MOH_2020-10-14_009387Phase 2Completed
- Sponsor
- פרופ ורנון פיטר ואן ירדן
- Start
- Oct 2020
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Allocetra in coronavirus disease 2019 (COVID-19), sponsored by פרופ ורנון פיטר ואן ירדן. Started Oct 2020; status: completed.
02
Drugs
Allocetra
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on MOH_2020-10-14_009387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-10-14_009387.